Sponsors looking to increase diversity in clinical trials should, among other things, “meet patients where they are,” hire a more diverse pool of trial investigators, train nonminority investigators, and deploy a patient-centric model for trials that includes input from Community Advisory Boards (CABs).
展开▼
